journal article·2022-08-24

Nanotrains of DNA Copper Nanoclusters That Triggered a Cascade Fenton-Like Reaction and Glutathione Depletion to Doubly Enhance Chemodynamic Therapy

Qianqian Li, Fei Wang, Lu Shi, Qiaorong Tang, Baoxin Li, Xiaobing Wang, Yan Jin

ACS Applied Materials & Interfaces· Volume 14· Issue 33
Publisher page

Abstract

Many current chemodynamic therapy (CDT) strategies suffer from either low therapeutic efficiency or the deficiency of poor targeting. The low therapeutic efficiency is mainly ascribed to the intracellular antioxidant system and the inefficient Fenton reaction in the weakly acidic tumor microenvironment (TME). Herein, by exploitation of the diverse function and programmability of functional nucleic acid, aptamer-tethered nanotrains of DNA copper nanoclusters (aptNTDNA-CuNCs) were assembled to simultaneously achieve targeted recognition, loading, and delivery of CDT reagents into tumor cells without an external carrier. The intracellular hydrogen peroxide (H2O2) oxidized nanotrains of DNA-CuNCs to produce a lot of Cu2+ and Cu+ ions, which can generate reactive oxygen species (ROS) in the weakly acidic TME based on the pH-independent Fenton-like reaction of Cu+/H2O2. Meanwhile, the redox reaction between intracellular glutathione (GSH) and Cu2+ depleted GSH and generated Cu+ ions, which weakened the antioxidant ability of cancer cells and further enhanced the Fenton-like reaction of Cu+/H2O2, respectively. Thus, the cascade Fenton-like reaction and GSH depletion doubly improved the efficacy of CDT. The in vivo and in vitro study solidly confirmed that aptNTDNA-CuNCs have excellent antitumor efficacy and no cytotoxicity to healthy cells. Therefore, aptNTDNA-CuNCs can act as CDT reagents to achieve highly efficient, biocompatible, and targeted CDT.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi’an, Shaanxi 710119, China

Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi’an, Shaanxi 710119, China

Funding

Central University Basic Research Fund of China · National Natural Science Foundation of China · Natural Science Foundation of Shaanxi Province

References (51)

Show source-provided references
1. 10.1021/acs.nanolett.9b0159510.1021/acs.nanolett.9b01595 ↗
2. 10.1039/C9TB00525K10.1039/C9TB00525K ↗
3. 10.1021/acsnano.8b0030910.1021/acsnano.8b00309 ↗
4. 10.1002/adma.20180820010.1002/adma.201808200 ↗
5. 10.1021/acsnano.7b0774610.1021/acsnano.7b07746 ↗
6. 10.1021/acs.nanolett.8b0240910.1021/acs.nanolett.8b02409 ↗
7. 10.1002/anie.20180566410.1002/anie.201805664 ↗
8. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
9. 10.1021/acsami.9b1347010.1021/acsami.9b13470 ↗
10. 10.1021/jacs.0c0560410.1021/jacs.0c05604 ↗
11. 10.1002/anie.20210209710.1002/anie.202102097 ↗
12. 10.1002/adma.20180222810.1002/adma.201802228 ↗
13. 10.1021/acs.chemmater.8b0225110.1021/acs.chemmater.8b02251 ↗
14. 10.1021/acs.nanolett.8b0390510.1021/acs.nanolett.8b03905 ↗
15. 10.1039/C8MH01176A10.1039/C8MH01176A ↗
16. 10.1002/smll.20180379110.1002/smll.201803791 ↗
17. 10.1021/acs.nanolett.9b0355610.1021/acs.nanolett.9b03556 ↗
18. 10.1021/jacs.9b1287310.1021/jacs.9b12873 ↗
19. 10.1021/acs.nanolett.9b0412510.1021/acs.nanolett.9b04125 ↗
20. 10.1021/acsami.0c2100610.1021/acsami.0c21006 ↗
21. 10.1021/acsami.9b1867610.1021/acsami.9b18676 ↗
22. 10.1002/adma.20170400710.1002/adma.201704007 ↗
23. 10.1021/acsami.9b0932310.1021/acsami.9b09323 ↗
24. 10.1016/j.jconrel.2015.08.05010.1016/j.jconrel.2015.08.050 ↗
25. 10.1021/acsnano.1c0107710.1021/acsnano.1c01077 ↗
26. 10.1002/anie.20191276810.1002/anie.201912768 ↗
27. 10.1002/anie.20201441510.1002/anie.202014415 ↗
28. 10.1021/acsami.8b0020710.1021/acsami.8b00207 ↗
29. 10.1021/acsnano.1c0049810.1021/acsnano.1c00498 ↗
30. 10.1002/adma.20200243910.1002/adma.202002439 ↗
31. 10.1080/10717544.2018.145892010.1080/10717544.2018.1458920 ↗
32. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
33. 10.1002/anie.20200778610.1002/anie.202007786 ↗
34. 10.1021/acsnano.8b0938710.1021/acsnano.8b09387 ↗
35. 10.1002/adma.20210422310.1002/adma.202104223 ↗
36. 10.1021/jacs.9b0350310.1021/jacs.9b03503 ↗
37. 10.1002/adhm.20190019210.1002/adhm.201900192 ↗
38. 10.1021/acsnano.0c0644610.1021/acsnano.0c06446 ↗
39. 10.1016/j.bios.2016.09.05510.1016/j.bios.2016.09.055 ↗
40. 10.1002/anie.20130463110.1002/anie.201304631 ↗
41. 10.1021/acs.analchem.6b0448410.1021/acs.analchem.6b04484 ↗
42. 10.1039/C5RA14852A10.1039/C5RA14852A ↗
43. 10.1016/j.saa.2013.08.09710.1016/j.saa.2013.08.097 ↗
44. 10.1021/jacs.9b1075510.1021/jacs.9b10755 ↗
45. 10.1016/j.saa.2022.12093710.1016/j.saa.2022.120937 ↗
46. 10.1039/D0AN01291B10.1039/D0AN01291B ↗
47. 10.1039/C6AN00233A10.1039/C6AN00233A ↗
48. 10.1002/anie.20090725610.1002/anie.200907256 ↗
49. 10.1002/anie.20200390510.1002/anie.202003905 ↗
50. 10.1002/anie.20220590910.1002/anie.202205909 ↗
51. 10.1002/anie.20171202710.1002/anie.201712027 ↗